The Patent Finder
TI

Thermolife International, LLC

First filing 2007
OverviewNotableFeesChangesFamiliesPatent listSources & methods

66 patents currently held

1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.

The next US patent term in the Thermolife International, LLC portfolio ends in Dec 2027, and more of its terms end in 2027 (33) than in any other year. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
40
Ending by 2030
Dec 2027
Next term end
15
Patent families

When these terms end

Held patents by the year their term ends
notable patents all others Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Amino Acid Compositions US 8,466,187
Cited by 61 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2027 · High confidence
Also notable
Hexylamine Salts and Methods of Using Hexylamine US 11,541,020
Cited by 6 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2040.
Ends Sep 2040 · High confidence
Also notable
Creatine And/Or Creatinine Compositions and Related Methods US 11,154,499
A family of 5 related applications built on the 2021 grant. Protection runs to 2039.
Ends Mar 2039 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Glutaurine Compositions and Therapeutic Uses Thereof (US 10,420,739) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 3 fees due Apr 1 to 8, 2027 · next Apr 1
  • 3 fees due May 12 to 26, 2027 · next May 12
  • 1 fee due Jul 9, 2027
    The maintenance fee for Method of Treating Migraines and Headaches (US 11,865,139) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 24, 2026

What they patent

The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,569,368Amino Acid Compounds
In force
 · High confidence
In forceHigh confidence
US 8,569,369Amino Acid Compounds
In force
 · High confidence
In forceHigh confidence
US 8,952,045Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
US 8,952,046Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
US 8,952,047Betaine Compounds
In force
 · High confidence
In forceHigh confidence
US 8,957,100Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
US 8,957,101Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
US 10,426,750Amino Acid Supplement Formulations
In force
 · High confidence
In forceHigh confidence
US 10,426,792Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
US 10,435,356Amino Acid Compositions
In force
 · High confidence
In forceHigh confidence
10 of 66 patents shown.
Pro members see all 66.
Pro members: see all 66 patents
Also on record, not counted in the 66: 1 patent in force now held by others · 1 patent ended · 44 applications pending · 27 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited